Dr Barker has performed hematopoietic stem cell transplantation for over 25 years. Her research has investigated strategies to extend allogeneic transplantation to racial/ ethnic minorities and other underserved patients using alternative stem cell sources with a special focus on neonatal cord blood (CB). Dr Barker has pioneered multiple approaches that have under-scored modern CB transplantation. Since 2005, her work has highlighted the need to study the access of diverse ancestral groups to curative allogeneic transplantation. Having previously acted as an advisor to the National Marrow Donor Program, Dr Barker is now a member of the U.S. government HRSA Advisory Council on Blood Stem Cell Transplantation, and she Chairs the National Cord Blood Network consortium. As Director of the Bone Marrow Transplant and Cellular Therapy Program at Weill Cornell Medicine/NewYork-Presbyterian (WCM/NYP), her aim is to facilitate the extension of access to state-of-the-art transplantation and cellular therapy to all patients including the under-served, conduct research including strategies to improve the delivery of complex cancer care, and continue her career of mentoring trainees, faculty and other health care professionals in this field.